Metric Finance
LearnFAQ
LearnFAQ

Learn / LH

NYSE: LH

Labcorp Holdings (LH) stock, explained like you're 5

Labcorp Holdings trades on the New York Stock Exchange under the ticker LH. It is a large cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 25.3 billion dollars.

Ticker
LH
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Medical Specialities
Size
Large cap, about 25.3 billion dollars

Is Labcorp Holdings a small, medium or large cap company?

Yes. Labcorp Holdings is a large cap stock. Its market cap, which is the total value of all its shares, is about 25.3 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Labcorp Holdings makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves LH stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Labcorp (LH) Stock Looks In Step With Its Cash Flow Outlook (Yahoo Finance)
  • Labcorp Holdings Inc. stock underperforms Friday when compared to competitors (MarketWatch)
  • A prostate cancer blood test may reach more patients if Labcorp completes its deal (Stock Titan)
  • Q2 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks (StockStory)
  • Why Is Opko Health Stock Gaining Thursday? OPKO Health (NASDAQ:OPK), Labcorp Holdings (NYSE:LH) (Benzinga)

Follow LH in your daily brief

Each trading day at 5 PM ET we post what happened to Labcorp Holdings and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow LH

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Labcorp Holdings stock

What does Labcorp Holdings do?

Labcorp Holdings trades on the New York Stock Exchange under the ticker LH. It is a large cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 25.3 billion dollars.

What is the ticker symbol for Labcorp Holdings?

Labcorp Holdings trades under the ticker LH on the New York Stock Exchange.

What is Labcorp Holdings's market cap?

Labcorp Holdings is a large cap stock with a market cap of about 25.3 billion dollars.

How does Labcorp Holdings make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves LH stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow LH stock every day?

Add LH to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow LH daily

A free brief on Labcorp Holdings and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • UNH · Unitedhealth Group
  • NTRA · Natera
  • ILMN · Illumina
  • CNC · Centene

Similar stocks

  • UNHUnitedhealth Group
  • NTRANatera
  • ILMNIllumina
  • CNCCentene

Compare LH: LH vs UNH, LH vs NTRA, LH vs ILMN

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed